Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590044 · ClinicalTrials.gov registry record · Phase 4
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
NCT00590044 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 74 participants.
The verdict
NCT00590044, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
Study Summary
The study is a multicenter, randomized controlled trial to compare the safety and efficacy of insulin analogs and human insulins both during acute intravenous treatment and during the transition to subcutaneous insulin in patients with diabetic ketoacidosis (DKA).
Interventions
- DRUG insulin glargine+ glulisine
- DRUG NPH + Regular insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590044
The ClinicalTrials.gov registry entry for NCT00590044 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which insulin glargine+ glulisine is the first listed.
NCT00590044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590044 about?
NCT00590044 is a clinical study titled "Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)". The study is a multicenter, randomized controlled trial to compare the safety and efficacy of insulin analogs and human insulins both during acute intravenous treatment and during the transition to subcutaneous insulin in patients with diabetic ketoacidosis (DKA).
What is the current status of trial NCT00590044?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2007-12. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00590044?
The interventions under investigation include: insulin glargine+ glulisine (DRUG), NPH + Regular insulin (DRUG).
Who is sponsoring clinical trial NCT00590044?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.